{"org_id": "T000126027", "org_name_cn": "博瑞生物医药(苏州)股份有限公司", "org_short_name_cn": "博瑞医药", "org_name_en": "Brightgene Bio-Medical Technology Co.,Ltd.", "org_short_name_en": "BrightGene", "main_operation_business": "致力于研发和生产高端仿制药和原创性新药的高科技制药。", "operating_scope": "　　研发大环内酯、多肽、多糖、杂环、唑类、嗪类、苯醚类、四环素类化合物，生产非药品类大环内酯、多肽、多糖、杂环、唑类、嗪类、苯醚类、四环素类化合物，销售本公司所生产的产品，并提供有关技术咨询和技术服务（不涉及药品生产许可证管理范围和国家外商投资产业指导目录限制类和禁止类产品）。", "district_encode": "320506", "org_cn_introduction": "博瑞生物医药(苏州)股份有限公司致力于研发和生产高端仿制药和原创性新药的高科技制药企业。主要从事高技术壁垒的医药中间体、原料药和制剂产品的研发和生产业务,主要产品为抗体药物、疫苗、核酸药物和细胞治疗产品、产业化技术、重组蛋白质药物,公司先后获得“国家知识产权示范企业”(国家知识产权局授予),“国家知识产权优势企业”(国家知识产权局授予),“2017年度中国专利优秀奖”(国家知识产权局授予),“第十一届中国药学会科学技术奖一等奖”等荣誉。", "legal_representative": "袁建栋", "general_manager": "袁建栋", "secretary": "王征野", "established_date": 1004025600000, "reg_asset": 410000000.0, "staff_num": 745, "telephone": "86-512-62620988", "postcode": "215123", "fax": "86-512-62551799", "email": "ir@bright-gene.com", "org_website": "www.bright-gene.com", "reg_address_cn": "江苏省苏州市吴中区工业园区星湖街218号生物纳米园C25栋", "reg_address_en": "", "office_address_cn": "江苏省苏州市吴中区工业园区星湖街218号生物纳米园C25-C28栋", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1573142400000, "provincial_name": "江苏省", "actual_controller": "袁建栋 (27.69%)，钟伟芳 (13.84%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "袁建栋", "executives_nums": 14, "actual_issue_vol": 41000000.0, "issue_price": 12.71, "actual_rc_net_amt": 439984600.0, "pe_after_issuing": 72.46, "online_success_rate_of_issue": 0.04802309, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}